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Abstract
Background: Type I interferons, including interferon alpha (IFN-a), represent one of the first lines of innate
immune defense against influenza virus infection. Following natural infection of chickens with avian influenza virus
(AIV), transcription of IFN-a is quickly up regulated along with multiple other immune-related genes. Chicken IFN-a
up regulates a number of important anti-viral response genes and has been demonstrated to be an important
cytokine to establish anti-viral immunity. However, the mechanisms by which interferon inhibit virus replication in
avian species remains unknown as does the biological activity of chicken interferon in other avian species.
Methods: In these studies, we assessed the protective potential of exogenous chicken IFN-a applied to chicken,
duck, and turkey primary lung cell cultures prior to infection with the pandemic H1N1 virus (A/turkey/Virginia/SEP-
4/2009) and an established avian H5N9 virus (A/turkey/Wisconsin/1968). Growth kinetics and induction of select
immune response genes, including IFN-a and myxovirus-resistance gene I (Mx), as well as proinflammatory
cytokines (IL-1b and IL-6), were measured in response to chicken IFN-a and viral infection over time.
Results: Results demonstrate that pretreatment with chicken IFN-a before AIV infection significantly reduced virus
replication in both chicken-and turkey-origin lung cells and to a lesser degree the duck-origin cells. Virus growth
was reduced by approximately 200-fold in chicken and turkey cells and 30-fold in duck cells after 48 hours of
incubation. Interferon treatment also significantly decreased the interferon and proinflammatory response during
viral infection. In general, infection with the H1N1 virus resulted in an attenuated interferon and proinflammatory
response in these cell lines, compared to the H5N9 virus.
Conclusions: Taken together, these studies show that chicken IFN-a reduces virus replication, lower host innate
immune response following infection, and is biologically active in other avian species.
Keywords: avian influenza, interferon, chicken, duck, turkey
Background
Avian influenza (AI) is a viral disease of poultry that can
occur in many different bird species, with wild aquatic
birds, including ducks, considered the natural reservoir
for the AI viruses in the environment [1]. Both high and
low pathogenic avian influenza viruses are continually
being isolated from wild and domestic species of birds,
causing concern of outbreaks in the poultry industry. In
addition, recent outbreaks of human infections caused by
influenza viruses containing genes of avian lineage,
including H1N1, H5N1, H7N2, H7N3, H7N7, and H9N2,
demonstrates that AI viruses can be transmitted directly
to humans from domestic poultry [2]. Thus, domestic
poultry can act as intermediate hosts for the transmission
of influenza viruses from wild aquatic birds to humans
due to the inherent closeness of rearing.
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secreted from most all eukaryotic cells in response to
external signals. They are classified into three groups,
designated type I, type II and type III. Type I IFN (a and
b), are expressed rapidly after viral infection, and repre-
sent a first line of defense initiated by the innate immune
response. Chicken type I IFN (ChIFN) was the first IFN
to be discovered over 50 years ago and was described as a
virus-induced factor able to interfere with influenza virus
replication in chorioallantoic membranes of chicken
embryos [3]. IFNs generally have been considered to be
host species specific, yet it is known that several IFN pro-
teins show various degrees of cross-species activity. Tur-
key IFN-a shares 91% and 82% identity with chicken
IFN-a at the nucleotide (nt) and amino acid (aa)
sequence levels, respectively. Duck IFN (DuIFN) is 73%
identical to the ChIFN at the nt level but only 50% identi-
cal at the aa level [4]. Bertram et al. reported functional
homology in supernatants of PHA-stimulated chicken
and duck lymphocytes using in vitro proliferation assays
[5]. Chicken and turkey type I IFN have also been shown
to be cross-reactive [6]. However, at least one report indi-
cates that natural DuIFN has little or no cross-reactivity
on chicken cells [7].
Immediately following infection of chickens with avian
influenza virus (AIV) most cells begin to express proin-
flammatory cytokines, including IL-1b and IL-6, and
Type I IFN genes, which results in a general antiviral
response through the activation of a broad range of effec-
tor molecules, including Myxovirus resistance gene I
(Mx), RNA-activated protein kinase (PKR) and 2’,5’-oli-
goadenylate synthetases (OAS) [8-10]. Chickens have a
single Mx gene (Mx1)t h a ti si n d u c e db yt y p eII F N[ 1 1 ] .
The original evaluation of chicken Mx1 indicated the
encoded protein lacked antiviral activity [12]. Ko et al.,
however, reported that the chicken Mx1 gene is highly
polymorphic, and cDNAs of some but not all Mx1 alleles
transfected into mouse 3T3 cells conferred protection
against vesicular stomatitis virus (VSV) and highly patho-
genic AI in vitro [13]. Recently, we demonstrated in vivo
differences against AI in chickens with Mx1 variant
alleles [14]. At least one report indicates duck Mx does
not enhance resistance to influenza virus [15].
Beginning in April 2009, cases of acute respiratory dis-
ease were reported in humans and swine in Mexico caused
by a novel H1N1 influenza A virus which was subse-
quently declared a pandemic [16]. Reports of the pH1N1
virus in turkeys was first observed in Chile, and later in
North America on turkey breeder farms in Virginia and
California, as well as Canada http://www.ars.usda.gov/
2009h1n1/. The pH1N1 has also been detected in other
species including dogs [17] and ferrets [18]. The pH1N1 is
a triple reassortant virus containing genes from human
(PB1), avian (PB2, PA), and swine (HA, NP, NA, M, NS)
influenza viruses. The presence of avian and swine influ-
enza virus genes in the pH1N1 raises the potential for
infection in poultry following exposure to infected humans
or swine. This is especially true for turkeys because of
their known susceptibility to type A influenza viruses and
the history of infection with triple reassortant viruses
[19-22].
Our understanding of the immunological response to
avian influenza by different avian species is largely
unknown. In this study, we compared the growth
kinetics of two avian influenza viruses containing both
mammalian and avian origin genes (H1N1), or avian
genes only (H5N9), in primary lung cell cultures from
three common domestic poultry species (chicken, duck
and turkey). The influence of chicken IFN-a on viral
replication and host innate immune response genes fol-
lowing infection was also determined. Overall, chicken
IFN-a reduced virus replication in all cell lines tested
and decreased interferon and proinflammatory responses
following AIV infection.
Results
Pretreatment with rChIFN-a inhibits AIV replication
To investigate the antiviral potential of chicken IFN-a
against AIV in vitro, chicken, duck, and turkey primary
lung cells were pretreated with 1000 U/ml rChIFN-a
for18 hours prior to infection and viral growth was mea-
sured over 48 hours. As show in Figure (1A and 1C), at 2
hpi, reduced viral titers were first observed in chicken
and turkey lung cell cultures pretreated with rChIFN-a.
From 12 to 48 hpi, rChIFN-a significantly reduced virus
replication compared to sham-treated cells (P < 0.05). At
24 and 48 hpi, virus growth was reduced by approxi-
mately 200-fold in both chicken and turkey lung cells. In
duck lung cells, results demonstrate that pretreatment
with rChIFN-a before AIV infection reduced virus repli-
cation, albeit to a lesser degree than observed with
chicken or turkey cells (Figure 1B). At 2 hpi, no reduc-
t i o ni nv i r u st i t e rw a so b s e r v e d .F r o m1 2t o4 8h p i ,a
reduction of virus titer was observed by approximately
30-fold in duck cells. Although no statistical difference
was observed, a biological difference is apparent. These
data demonstrate that rChIFN-a can reduce virus repli-
cation and is biologically active in other avian species.
Pretreatment with rChIFN-a inhibits H1N1 and H5N9 virus
NP expression
To further demonstrate rChIFN-a pretreatment inhibits
the replication of AIV, immunofluorescence assays to
detect viral nuclear protein were performed. Figure 2
demonstrates decreased levels of viral NP expression at
24 hpi in the rChIFN-a treated chicken lung cells than
untreated-infected cells with both H1N1 and H5N9 AIV.
Similar staining patterns were observed for both duck
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Figure 1 Recombinant ChIFN-a reduces avian influenza virus replication. Inhibition of avian influenza virus (H1N1 and H5N9) replication in
primary lung cell cultures derived from chicken (A), duck (B), and turkey (C) after rChIFN-a (1000 U/ml) pretreatment in vitro. Cells were infected
with A/turkey/Virginia/2009 H1N1 or A/turkey/Wisconsin/68 H5N9 at MOI 0.1. Supernatants were harvested at the times indicated and viral titers
were determined following injection into SPF embryos. The mean (and standard deviations) of three independent experiments are shown.
Different lowercase letters denote significance in titer following rChIFN-a treatment groups (within columns) (P < 0.05) as determined by one-
way ANOVA. Statistical differences (P < 0.05) following treatment between virus groups are shown by lowercase letter.
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Page 3 of 12and turkey lung cell cultures (data not shown). No stain-
ing was observed in any uninfected control cells. These
results indicated that the pretreatment of cells with
rChIFN-a strongly inhibits viral NP production.
Reduced CPE following rChIFN-a pretreatment following
AIV infection
The protective effect of rChIFN-a against CPE was deter-
mined in pretreated and virus-infected lung cell cultures.
In uninfected-control chicken lung cells with or without
IFN-a treatment, epithelial-like cell cultures were
observed with clearly defined nucleus and cytoplasm in
individual cells (Figure 3A and 3B). Morphologically, no
CPE was observed for lung cells pretreated with rChIFN-
a alone (Figure 3B). Additionally, chicken IFN-a was
noncytotoxic based on cell viability after 48 hours expo-
sure on all species tested (data not shown). Strong CPE
was observed in both the H1N1 (Figure 3C) and H5N9
(Figure 3E) infected cells at 24 hpi, including decreased
cell numbers and holes in monolayer with decreased
direct cell-to-cell contact. However, pretreatment of
monolayers with rChIFN-a abrogated the CPE observed
in the virus infected cultures (Figure 3D and 3F). These
results demonstrate that pretreatment of cells with
rChIFN-a protected cells against virus induced CPE.
Interferon-treatment attenuate the cytokine gene
expression
We next investigated the effects of rChIFN-a on the
innate immune response of avian lung cells to AIV using
quantitative real-time RT-PCR. AIV infected and
rChIFN-a pretreated cells were compared for induction
of IFN-a,M x ,I L - 1 b a n dI L - 6m R N Aa t1 2 ,2 4a n d4 8
hpi. In all cell types tested, IFN-a pretreatment did not
increase expression of the pro-inflammatory cytokines or
IFN-a, but did up regulate Mx gene expression 2-5 fold
(data not shown). In chicken lung cells, both H1N1 and
H5N9 viruses induced an increased IFN-a response com-
pared to sham-infected cells after infection that peaked
early and declined over time (Figure 4). In contrast,
rChIFN-a pretreatment resulted in a significant decrease
of IFN-a expression after viral infection. Expression of
the Mx gene was markedly higher in chicken lung cells
after viral infection, especially in the H5N9 group which
increased expression approximately 120-fold over the
sham-infected cells. However, rChIFN-a pretreatment
significantly reduced expression at all time points taken.
Both viruses tested up regulated the proinflammatory
cytokine genes, IL-1b and IL-6, after infection. Pretreat-
ment with rChIFN-a significantly reduced expression
compared to virus-infected cells. In general the H5N9
Ck
DD
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Tk
         Control                                   H1N1                                  IFN+H1N1   H5N9                                IFN+H5N9
Figure 2 Recombinant ChIFN-a inhibits pH1N1 and H5N9 virus nuclear protein expression. Primary chicken, turkey, and duck lung cells
were pretreated with or without rChIFN-a (1000 U/ml) for 18 h. Monolayers were infected with either H1N1 or H5N9 avian influenza virus (MOI
= 0.1) for 1 h, and replaced with fresh media. After 24 hours, cells were fixed and viral antigens were reacted with mouse-derived monoclonal
antibody (P13C11) specific for type A influenza virus nucleoprotein followed by detection with Texas Red-labeled goat anti-mouse IgG antibody.
Magnification 400×.
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Page 4 of 12virus stimulated a higher innate immune response in
chicken cells with the four genes examined than the
H1N1 virus.
In duck lung cells, neither H1N1 nor H5N9 viruses
induced an increased IFN-a response compared to
sham-infected cells (Figure 5). However, an increase in
Mx expression was observed after H5N9, but not H1N1,
infection that peaked with a 12-fold increase at 48 hpi.
Pretreatment of cells with rChIFN-a significantly
reduced Mx expression at all times tested. IL-6 gene
expression was only up regulated following H5N9 infec-
tion, whereas the H1N1 virus did not induce up regula-
tion of either IL-6 or IL-1b.
In turkey lung cells, both H1N1 and H5N9 viruses
induced an increased IFN-a response compared to sham-
infected cells that also peaked early after infection and
declined over time (Figure 6). rChIFN-a pretreatment sig-
nificantly decreased the magnitude of IFN-a expression
following H1N1 and H5N9 infection. Following virus
infection, expression of the Mx gene was markedly high
with both viruses inducing approximately 270-fold
increase. Interestingly, pretreatment with rChIFN-a
reduced Mx expression after virus infection, but not to the
levels observed in either the chicken or duck cells, which
were reduced to < 2 fold increase. Both viruses up regu-
lated the IL-1b and IL-6, after infection in turkey cells,
although the H5N9 stimulated a more robust response.
Pretreatment with rChIFN-a significantly reduced the
proinflammatory responses compared to virus-infected
cells.
Discussion
Avian influenza viruses present a permanent concern to
the poultry industry and the recent emergence of pan-
demic H1N1 and highly pathogenic avian influenza H5/
H7 subtypes serves as a reminder that influenza remains
a severe threat throughout the world. Beside vaccination,
there is an urgent need for new antiviral strategies to
protect and treat against influenza. A significant portion
of that strategy is to determine the influence of host-
derived immune proteins on virus replication. Because
AIV initially replicates on mucosal surfaces of avian spe-
cies, including the respiratory tract, we chose to compare
the immunological effect on replication in cells from this
tissue. We report here that pretreatment with rChIFN-a
before AIV infection reduced virus replication in chicken,
duck and turkey lung cells.
Our study demonstrates that rChIFN-a reduces virus
infection by limiting AIV replication, determined by
decreased viral titers and decreased production of viral
NP. The NP is important for maintaining the structure of
the ribonucleoprotin complex, as well as genome replica-
tion by interacting with viral RNA [23-25]. Thus a reduc-
tion of viral protein synthesis appears to be at least on
mechanism of anti-viral effect following rCHIFN-a treat-
ment. Previously, three mechanisms of antiviral effects
Control   H1N1   H5N9
  
  
Infected
A C E
IFNͲɲtreated
D B F
Figure 3 Reduced cytopathic effect following rChIFN-a pretreatment following AIV infection. Primary chicken lung cell monolayers were
pretreated with 1000 U/ml of rChIFN-a and infected with either H1N1 of H5N9 at 0.1 MOI. Negative control cells include no treatment/no virus
(A), and IFN-a only (B). Protection from cytopathic effect was observed in cells infected with virus only, H1N1 (C) and H5N9 (E), compared with
IFN-a treated cells that were then infected with H1N1 (D) or H5N9 (F). At 24 hpi the monolayers were digitally photographed using an inverted
microscope at 200× magnification (Olympus America Inc., Melville, NY).
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Page 5 of 12induced by IFN-a have been described in mice and
humans, including activation of PKR, OAS, and Mx. Both
PKR and OAS are important effector molecules that
mediate a cellular response to foreign RNA structures
[26,27]. Although neitherP K Rn o rO A Si n d u c t i o nw a s
measure in this study, we show here that rChIFN-a pre-
treatment does up regulate Mx in chicken, turkey and
duck cells, and positively correlated with decreasing virus
replication. Further studies to determine the nature of
viral inhibition with Mx proteins derived from different
avian species are ongoing.
Previous studies have shown that chicken IFN-a
administered to chicken by oral ingestion or intravenous
injection can inhibit avian viruses including H9N2 AIV,
Newcastle disease virus, infectious bursal disease virus,
infectious bronchitis virus, Rous sarcoma virus, and
Marek’s disease virus [28,29]. In our studies, the pre-
sence of rChIFN-a significant limited the ability of these
viruses to replicate, especially in the chicken and turkey
lung cell cultures. Previous research indicates that
chicken and turkey type I IFNs have been shown to be
cross-reactive, such that some level of cross protection
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Figure 4 Relative expression of select immune response genes following pretreatment of primary chicken lung cells with 1000 U/ml
rChIFN-a, and infection with H1N1 or H5N9, compared to control (untreated/uninfected) cells. The relative expression of IFN-a (A), Mx
(B), IL-6 (C), and IL-1b (D) was measured following mock treatment at various time points post infection in three independent experiments. RNA
from lung cells was normalized using the 28S house-keeping gene. Data are expressed as fold change in mRNA levels between interferon
treated and infected cells compared with those from untreated and uninfected (negative control) cells.
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Page 6 of 12was not unexpected in the turkey lung cells. The
rChIFN-a did not reduce titers on duck cells to the
level observed in the chicken or turkey lung cells. How-
ever, a moderate biological effect (> 1 log10 reduction)
was evident in the absence of statistical differences.
Because of the amino acid differences between chicken
and duck IFN, it seems likely that rChIFN-a is not as
efficient at inducing an antiviral effect in this species.
Whether this effect is due to decreased IFN-a receptor
affinity or downstream transcription factor activation for
cytokine expression remains to be determined.
When virus replication was compared between the
three kinds of primary lung cells, we observed that both
viruses replicate to the highest titers on the turkey lung
cells, followed by chicken lung cells and duck lung cells.
This data suggest that turkey may be more susceptible
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Figure 5 Relative expression of select immune response genes following pretreatment of primary duck lung cells with 1000 U/ml
rChIFN-a, and infection with H1N1 or H5N9, compared to control (untreated/uninfected) cells. The relative expression of IFN-a (A), Mx
(B), IL-6 (C), and IL-1b (D) was measured following mock treatment at various time points post infection in three independent experiments. RNA
from lung cells was normalized using the GADPH house-keeping gene. Data are expressed as fold change in mRNA levels between interferon
treated and infected cells compared with those from untreated and uninfected (negative control) cells.
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Page 7 of 12to H1N1 and H5N9 virus than white leghorn chickens
and Pekin ducks. This result may not be unexpected
since both viruses are of turkey origin and maybe be
better adapted for this species. These results also high-
light the role of turkeys as intermediate host in the
transmission of influenza viruses from domestic poultry
to humans. The detection of a2,3 (avian type) and a2,6
(mammalian type) sialic-acid-linked receptors in the tur-
keys further indicate that this species can replicate both
avian and mammalian viruses [19,30,31]. This is
consistent with some reports that turkeys were more
susceptible to disease from LPAI virus than chickens
and ducks [32-34].
Interestingly, interferon treatment significantly
decreased the interferon and proinflammatory response
after viral infection. The decreased proinflammatory
response positively correlated with decreased virus repli-
cation, and may explain the reason for this observation.
In addition, infection with the H1N1 virus produced a
decreased expression of the innate immune genes tested,
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Figure 6 Relative expression of select immune response genes following pretreatment of primary turkey lung cells with 1000 U/ml
rChIFN-a, and infection with H1N1 or H5N9, compared to control (untreated/uninfected) cells. The relative expression of IFN-a (A), Mx
(B), IL-6 (C), and IL-1b (D) was measured following mock treatment at various time points post infection in three independent experiments. RNA
from lung cells was normalized using the 28S house-keeping gene. Data are expressed as fold change in mRNA levels between interferon
treated and infected cells compared with those from untreated and uninfected (negative control) cells.
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Page 8 of 12including Mx, IL-1b and IL-6 than observed with the
H5N9 virus. This result is consistent with some recent
reports that indicate pandemic H1N1 isolates induce
weaker cytokines responses in human cells [35,36]. In
general, a robust cytokine response is associated with
highly pathogenic influenza viruses, including H5N1
viruses, and it is thought that this cytokine dysregulation
may contribute to disease severity [37]. Our results with
low pathogenic AI suggests that a suboptimal cytokine
response maybe in part explain how H1N1 could escape
the innate immune defense by impeding cytokine
response. This phenomenon maybe characteristic of low
pathogenic AI viruses as well since they also have
demonstrated the ability to limit the host’s antiviral Mx
response in chickens in vivo [38]. Data presented here
will contribute to a better understanding of the avian
host response to the low pathogenic AI viruses, and our
model of testing primary avian lung cell cultures will be
useful for monitoring new AIV isolates for changes in
innate immune modulation.
Conclusions
The present study demonstrates that pretreatment with
rChIFN-a prior to infection with the pandemic H1N1
and H5N9 avian influenza viruses not only significantly
reduced virus replication in both chicken-and turkey-
origin lung cells, and to a lesser degree the duck-origin
lung cells, but also significantly decreased the interferon
and proinflammatory response after viral infection.
Thus, under the scenario of avian influenza, rChIFN-a
might provide an additional option in the prevention
and therapy against low pathogenic AIV infection. Simi-
lar conclusions were recently described following oral
administration of rChIFN-a and H9N2 AIV infection
[28]. Further investigation into the molecular mechan-
isms of protection induced by chicken IFN-a are under-
way and will add more information on its anti-viral role.
Methods
Virus and cell culture infection
The low pathogenic AI viruses H1N1 A/turkey/Virginia/
SEP-4/2009 (H1N1) and H5N9 A/turkey/Wisconsin/68
(H5N9) were propagated in the allantoic cavities of 11
day of embryonating specific pathogen free (SPF) turkey
eggs. Viral titers were determined as previously
described [39]. All experiments using infectious virus
were conducted in a biosafety level 2 (BSL-2) facilities at
the Southeast Poultry Research Laboratory (SEPRL),
Agricultural Research Service, United States Department
of Agriculture (USDA) in Athens, Georgia.
Cells isolation and culture
Avian lung primary cells were isolated as described pre-
viously with minor modifications [40]. Briefly, lungs
from four-week-old specific pathogen-free (SPF) white
leghorn chickens, six-week-old SPF Beltsville White tur-
keys and eight-week-old commercial Pekin ducks were
aseptically collected and trypsinized before culturing in
12-well tissue culture plate coated with 0.01% (w/v) calf
skin collagen (Sigma Chemical Co., St. Louis, Mo.).
Cells were cultured at 1×10
6 lung cells per ml of Dul-
becco’s modified Eagle’s medium (DMEM) supplemen-
ted with 1% L-glutamine, 1% sodium pyruvate, 1%
MEM nonessential amino acids, 1% antibiotic-antimyco-
tic solution (Sigma), and 10% chicken serum in a humi-
dified incubator at 37°C. All animals used in these
studies were housed and handled in compliance with
our Institutional Animal Care and Use Committee
guidelines and procedures.
rChIFN-a treatment and virus infection
Lung cells were grown overnight in 12-well plates (Fisher
Scientific, Atlanta, Ga). Immediately before IFN treatment,
the cells were washed with warm PBS and subsequently
treated with 1000 U/ml of recombinant chicken IFN-a
(rChIFN-a, AbD Serotec Co., Oxford, UK) for 18 hours in
MEM containing 0.2% bovine albumin (BA) and antibio-
tics. After treatment, rChIFN-a was aspirated and cells
were washed with PBS. Thereafter, cells were inoculated
with H1N1 or H5N9 at a multiplicity of infection (MOI)
of 0.1 diluted in DMEM containing antibiotics for one
hour at 37°C with gentle agitation every 10 minutes. After
one hour of incubation, unabsorbed virus was removed
and cells were washed with PBS. Fresh media supplemen-
ted with 0.01 μg/ml TPCK trypsin (Sigma) were added per
well and the plate were incubated at 37°C and 5% CO2. At
0, 2, 12, 24 and 48 hours post infection (hpi), supernatants
were collected and stored at -80°C until used for titrations.
Lung cells were harvested for RNA extraction at 12, 24, 48
hpi. Virus titers was determined using the method of Reed
and Muench and expressed as log10 50% embryo infec-
tious dose (EID50) [41]. Controls included one plate with-
out virus and another one plate without either rChIFN-a
or virus. The plate was then incubated under the same
conditions as above.
Immunofluorescence assays for virus nuclear protein (NP)
To analyze antiviral effect of rChIFN-a on virus replica-
tion, primary avian lung cells were cultured on glass
cover slips in 24-well plate. After rChIFN-a treatment
and virus infection for 24 hours (as described above),
cells were washed with PBS twice, fixed and permeabi-
lized with ice-cold methanol. Viral antigens were
detected with mouse-derived monoclonal antibody speci-
fic for a type A influenza virus nucleoprotein (developed
at Southeast Poultry Research Laboratory, USDA) [42].
Cells were then stained with TRITC-conjugated
anti-mouse IgG antibody (Sigma). The stained cells
Jiang et al. Virology Journal 2011, 8:447
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Page 9 of 12were visualized with immunofluorescence microscopy
(Olympus America Inc., Melville, NY) under 400×
magnification.
Cytopathic effect (CPE) of rChIFN-a pretreatment on virus
infection
To visually compare virus inhibition following rChIFN-a
treatment, primary avian lung cells were seeded as above
on glass cover slips in 24-well plate. Following rChIFN-
a treatment, cells were virally infected as described
above. After 24 hours, the cells were fixed with ice-cold
acetone and CPE was visualized by inverted microscopy
(Olympus).
Isolation of RNA and analysis of cytokine expression by
real-time RT-PCR (RRT-PCR)
RNA was extracted using the RNeasy mini kit (Qiagen) in
accordance with the manufacturer’s instructions. Relative
cytokine expression in lung cells was examined by RRT-
PCR. IL-1b,I L - 6 ,I F N - a, and Mx expression were deter-
mined as previously described [14,43]. Briefly, quantitative
RRT-PCR was performed for each sample in triplicate in a
total volume of 25 μl, consisting of 12.5 μl iQ Sybrgreen
supermix (Bio-Rad Laboratories, Los Angeles, CA, USA)
with 1 μl of each primer at concentration of 10 pmol/μl,
5.5 μl RNase/DNase-free water, and 5 μld i l u t e dR N A .
PCR conditions were the same for each targeted gene and
are as follows: 10 min at 50°C, 95°C for 5 min, followed by
45 cycles of 95°C for 10 s and 56°C for 30 s. Primers for
chicken 28 s, IFN-a,I L - 1 b [ 1 4 ] ;t u r k e y2 8s ,I L - 1 b,I L - 6
[44]; duck GAPDH, IL-1b, IL-6, IFN-a [45] have been pre-
viously described. The other primers were designed using
the Primer Express software program (Applied Biosystems,
Foster City, California, USA) and sequences used in this
study for individual avian species are presented in Table 1.
The specificity for each primer set was tested by both sub-
jecting the PCR products to 1.5% agarose gel electrophor-
esis (data not shown) and analyzing the melting curve in
the iCycler iQ real-time PCR detection system (Bio-Rad)
after each real-time PCR reaction.
RNA from individual lung cell sample was normalized
using the 28S for chicken and turkey and GAPDH for
duck. For each gene, amplification was verified using
four 10-fold serial dilutions of standard spleen cell RNA
in the same PCR run. Expression was determined by the
standard curve method [46]. Data are expressed as fold
change in cytokine messenger RNA (mRNA) levels in
infected groups compared with those from uninfected,
untreated groups.
Statistical analyses
Data are expressed as the mean ± standard error. Statis-
tical differences were analyzed with Tukey one-way
ANOVA using Prism 5 (GraphPad Co., San Diego, CA).
All statistical tests were performed using P ≤ 0.05.
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